AR054113A1 - Forma cristalina solida de pantoprazol como acido libre, sales derivadas del mismo y proceso para su preparacion - Google Patents
Forma cristalina solida de pantoprazol como acido libre, sales derivadas del mismo y proceso para su preparacionInfo
- Publication number
- AR054113A1 AR054113A1 ARP060101834A ARP060101834A AR054113A1 AR 054113 A1 AR054113 A1 AR 054113A1 AR P060101834 A ARP060101834 A AR P060101834A AR P060101834 A ARP060101834 A AR P060101834A AR 054113 A1 AR054113 A1 AR 054113A1
- Authority
- AR
- Argentina
- Prior art keywords
- pantoprazol
- preparation
- same
- crystal form
- free acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Composiciones farmacéuticas que los contienen y métodos de preparacion. Reivindicacion 1: Un compuesto caracterizado porque es Pantoprazol ácido libre de la Forma III y sales derivados del mismo aceptables para uso farmacéutico. Reivindicacion 4: Una sal aceptable para uso farmacéutico de acuerdo con cualquiera de las reivindicaciones 1, 2 o 3, caracterizada porque dicha sal es una sal de sodio.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67821705P | 2005-05-06 | 2005-05-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR054113A1 true AR054113A1 (es) | 2007-06-06 |
Family
ID=37857100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060101834A AR054113A1 (es) | 2005-05-06 | 2006-05-05 | Forma cristalina solida de pantoprazol como acido libre, sales derivadas del mismo y proceso para su preparacion |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080262043A1 (es) |
EP (1) | EP1893602A2 (es) |
AR (1) | AR054113A1 (es) |
CA (1) | CA2607583A1 (es) |
WO (1) | WO2007036771A2 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7507829B2 (en) | 2002-12-19 | 2009-03-24 | Teva Pharmaceuticals Industries, Ltd | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
MXPA05013316A (es) | 2003-06-10 | 2006-03-17 | Teva Pharma | Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol. |
CN102199145B (zh) * | 2010-03-23 | 2013-09-18 | 山东新时代药业有限公司 | 一种治疗胃肠疾病的化合物 |
CN111057044A (zh) * | 2019-12-19 | 2020-04-24 | 北京民康百草医药科技有限公司 | 一种泮托拉唑钠倍半水合物单一晶型的制备方法 |
CN113461664A (zh) * | 2020-03-30 | 2021-10-01 | 北京新领先医药科技发展有限公司 | 一种制备泮托拉唑钠倍半水合物的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
ES2171116B1 (es) * | 2000-04-14 | 2003-08-01 | Esteve Quimica Sa | Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol. |
CN1876647A (zh) * | 2001-02-02 | 2006-12-13 | 特瓦制药工业有限公司 | 苯并咪唑化合物产品 |
US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
US7507829B2 (en) * | 2002-12-19 | 2009-03-24 | Teva Pharmaceuticals Industries, Ltd | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
ES2245277T1 (es) * | 2003-03-12 | 2006-01-01 | Teva Pharmaceutical Industries Limited | Solidos cristalinos y amorfos de pantoprazol y procedimientos para su preparacion. |
-
2006
- 2006-05-05 EP EP06831533A patent/EP1893602A2/en not_active Withdrawn
- 2006-05-05 AR ARP060101834A patent/AR054113A1/es unknown
- 2006-05-05 WO PCT/IB2006/001968 patent/WO2007036771A2/en active Application Filing
- 2006-05-05 US US11/913,732 patent/US20080262043A1/en not_active Abandoned
- 2006-05-05 CA CA002607583A patent/CA2607583A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1893602A2 (en) | 2008-03-05 |
CA2607583A1 (en) | 2007-04-05 |
WO2007036771A2 (en) | 2007-04-05 |
US20080262043A1 (en) | 2008-10-23 |
WO2007036771A3 (en) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR058348A1 (es) | Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden | |
UY33500A (es) | Derivados de acil sulfonamida y sus sales farmacéuticamente aceptables para uso en medicina | |
ECSP078030A (es) | Formas cristalinas y otras formas de las sales de ácido láctico de 4-amino-5-fluoro-3-[6-(4-metilpiperazin -1-il)-1h-bencimidazol-2 -il]-1h-quinolin-2-ona | |
AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
UY31870A (es) | Receptor metabotrópico de glutamato potenciadores 286 | |
GT200600518A (es) | Derivados de pirimidina | |
BR112014009087A2 (pt) | formulações de etanercept estabilizadas com xilitol | |
CU20140068A7 (es) | Triazolopiridinas sustituidas | |
UY32062A (es) | Inhibidores de beta-secretasa | |
AR076753A1 (es) | Derivados de carboxamida y urea aromaticas sustituidas como ligandos del receptor de vanilloides. | |
NI201200184A (es) | Morfolinopirimidinas y su uso en terapia | |
UY31046A1 (es) | Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones | |
CR10027A (es) | Nuevos derivados de pirrol fusionado | |
CY1112653T1 (el) | Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης | |
BR112014010576B8 (pt) | compostos inibidores de neprilisina (nep), seus usos, processo de preparação dos compostos e composição farmacêutica compreendendo os compostos | |
AR058293A1 (es) | Sales profarmacos y formulaciones de 1-[5-(4-amino-7-isopropil-7h-pirrolo[2,3-d]pirimidin-5-carbonil)-2-metoxi-fenil]-3-(2,4-dicloro-fenil)-urea | |
UY32490A (es) | Inhibidores de beta-secretasa | |
BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
ECSP088700A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
CU24330B1 (es) | Derivados del ácido 4-((1,1) bifenil-4-il)-3-(3-fosfonopropanamido) butanoico, activos como inhibidores de nep (endopeptidasa neutral) | |
ECSP13013011A (es) | Triazolopiridinas | |
CL2020001090A1 (es) | Compuesto de pirimidina como inhibidor de las janocinasas. | |
CR9703A (es) | Derivados de pirazolona | |
CU20120171A7 (es) | Triazolopiridinas sustituidas | |
UY29325A1 (es) | Nuevos derivados de 2 - amino-piridina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |